Neuronano AB is developing a biocompatible multichannel electrodes that minimize foreign body reactions providing superior performance.

Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN.

Engages in the development and domestic implantable medical devices

The Francis Crick Institute is a biomedical discovery institute dedicated to understanding the scientific mechanisms of living things. Its work is helping to understand why disease develops and to find new ways to treat, diagnose and prevent illnesses such as cancer, heart disease, stroke, infections, and neurodegenerative diseases. By bringing together scientists from many disciplines, the Crick will help to improve people's lives and keep the UK at the forefront of innovation in medical research, attracting high-value investment and strengthening the economy.

Mitech Corp, a subsidiary of GSE Systems, Inc., is a company headquartered in Chelmsford, MA, that develops and supplies event and alarm management and reporting software tools. The firm was founded by Zhao Wei Jin. On May 04, 1999 GSE Systems, Inc. acquired Mitech Corp for $0.35 million.

Guangzhou Yuxin Sensing Technology Co., Ltd., established on 2016-12-09, Business scope includes commodity wholesale trade(Except for licensed and approved products);Health Sciences Program Research,to develop;Commodity retail trade(Except for licensed and approved products);Auto Parts Retail;Materials Science Research,technology development;electronic,Communication and Automatic Control Technology Research,to develop;Research and Development of Communication Technology,Technical Services;Auto Parts Wholesale;Operation of non-licensed medical devices;

Ad-Tech Medical Instrument Corporation is the leading and well respected manufacturer and distributor worldwide of intra-cranial monitoring devices (“electrodes”) for the treatment of intractable epilepsy as well as complimentary neurosurgical instrumentation. The Company’s electrode devices are used for long-term EEG monitoring, mapping, SEEG, and stimulation of the brain for persons with intractable epilepsy and other brain diseases/disorders. Ad-Tech proprietary designs include subdural strip and grid electrodes, dual sided subdural electrodes, depth electrodes, depth electrodes with micro contacts, foramen ovale electrodes, intra operative electrodes, cranial nerve electrodes and spinal electrodes as well as related products including electrode placement kits/accessory placement devices and brain biopsy needles. The Company’s devices feature design elements such as advanced materials and components as well as field leading ease of use and connectivity, utilizing Ad-Tech’s patented connection systems. Ad-Tech’s devices are recognized for their elegant design, attention to the neurosurgeons requirements and simplicity of construction, resulting in safe and effective devices. With over 30 years of designing and manufacturing high-quality medical devices, Ad-Tech has cultivated a reputation for innovative designs, quality driven manufacturing, and proven performance in the field of neuro-monitoring and neurosurgery. The Company’s reputation for innovative designs dates back to 1985 with Ad-Tech’s creation of strip electrodes for long-term monitoring in the treatment of intractable epilepsy, which has become a market-leading position in the treatment of intractable epilepsy. As an example, Ad-Tech’s electrode designs were the first to use a “tunneling” technique to minimize the risk for CSF leakage. And Ad-Tech’s depth electrode design is considered the “gold standard” in it’s field. Over the course of Ad-Tech’s history, the Company has continued to develop innovative devices for intracranial monitoring and that has lead to it’s expansive offering as well as a pipeline for additional offerings. The Company’s reputation for innovation and quality are reinforced by a history of consistent performance in the field.

Oxford Biosensors Ltd. develops and manufactures hand-held diagnostic testing devices. It offers electrochemical biosensors based on screen printed electrodes and solid electrodes. ELECTROCHEMICAL SENSORS FOR SURFACE SCIENCE AND ANALYTICAL MEASUREMENTS Oxford Biosensors is focused on product development and licensing key technologies for water quality monitoring devices based on electrochemical (bio)sensors and point-of-care testing equipment.

Axion BioSystems develops multi-electrode array technology to provide access to cellular information analysis for research, clinical, and drug discovery markets. It offers single-well systems, stimulating and recording channels, channel systems, multi-well systems, and integrated circuits for elimination of stimulation artifacts. The company is based in Atlanta, Georgia.

Aleva Neurotherapeutics develops the next generations of implantable Deep Brain Stimulation systems, based on a MEMS technology. Our unique microfabricated devices enable Target Specific Stimulation and optimization of current therapies. They will also permit targeting new areas of the brain and the measurement of neurophysiological activity, translating into faster, more certain surgical placement of electrode leads. The first application will be in Deep Brain Stimulation for indications such as Parkinson's Disease and Essential Tremor. To maximize the value it can capture from its technology, Aleva intends to develop a series of two therapeutic products, while eliminating technological and clinical development risks at each stage. Our first product, directSTIM, an intelligent directional electrode connected to a best-in-class Deep Brain Stimulation system, has successfully completed an acute clinical trial at the Inselspital in Bern, Switzerland. It is currently further developped for a long term use. Aleva has been was founded in 2008 in Lausanne, Switzerland. It has raised 42 MUSD to date from prominent VCs, private investors and a strategic investor. The company is ISO13485 certified.

The Leibniz Institute for Neurobiology is a German research institute of neuroscience in Magdeburg, focusing on learning and memory. The institute was founded in 1992 and belongs to the Leibniz Association.

Waveguider Optical Telecom Technology, Inc. develops MEMS sensor and sensing signal integration chip. Its products include Fetal Doppler, Dynamic Thermometer, Watch for Seniors and Health Touch. The company was founded in 2008 and is headquartered in Shenzhen, China.

BOE Technology Group Co., Ltd. provides intelligent interface products and services for information interaction and human health as an Internet-of-Things company. It operates through three segments, namely Display Device and Sensor Device Business, Smart System Business, and Healthcare Service Business. Display Device and Sensor Device Business segment offers display, senor, and application solutions. Smart System Business segment provides intelligent manufacturing services, Internet-of-Things solutions, and a digital art Internet-of-Things platform. Healthcare Service Business segment offers a mobile healthcare Internet-of-Things platform and smart healthcare services. The company was founded on April 9, 1993 and is headquartered in Beijing, China.

Creo Medical Ltd. develops, manufactures and commercializes medical device technologies. It offers CROMA system, an electrosurgical unit that delivers bipolar radiofrequency power for the purpose of cutting, and microwave power for the purpose of coagulating tissue to staunch bleeding vessels. The firm also offers RS2 instrument, a retractable injection needle for tissue lift and irrigation. The company was founded by Christopher Paul Hancock and Steven Morris in 2003 and is headquartered in Chepstow, the United Kingdom.

Microarray Ltd. provides wound healing services. It offers wound dressing product development, marketing and sales; electrochemistry and diagnostic sensor technologies; biochemistry, oxygen and iodine chemistry; enzymology, immunology and inflammation. The firm��s research and development activities are concentrated on innovative, electrochemically-active wound dressings for the treatment of chronic wounds and on wound care diagnostics. The company was founded in 2000 and is headquartered in Bedford, the United Kingdom.

Boston Scientific Neuromodulation Corp. offers implantable pain management devices for neuromodulation. The company is headquartered in Marlborough, MA.

De Nora is an Italian multinational leader in sustainable technologies, that offers energy saving products and water treatment solutions. Globally. De Nora is the largest provider of insoluble electrodes for electrochemical processes (Chlorine & Caustic, Electronics & Surface Finishing, Pools Electro-chlorination, Cathodic protection, Energy storage & fuel cells) and is among the leaders in technologies and processes for filtration and disinfection of water (drinking water, industrial and municipal water treatment, ballast water & marine wastewater). The Company has grown internally through continuous innovation and externally with major acquisitions in USA, Japan, England and Italy. It is present in 12 countries worldwide with 23 offices, 12 manufacturing facilities and R&D centers in Italy, USA and Japan. The Group currently owns 355 patent families with more than 2,700 territorial extensions.